The year ahead feels like a long stretch of unwrapped gifts. Some days are bright boxes with bows; others are wrinkled wrapping paper hiding something unexpected. For me, living with sickle cell ...
Agios secured FDA approval for Acvezmi in thalassemia (Dec. 23) and is launching in the U.S. targeting ~4,000 adult patients with a list price of $425,000/year, supported by a ~40-person sales force, ...
Hosted on MSN
Predicting the onset of lithium plating using full-cell voltage: A pseudo-P curve approach
The research team introduces a novel experimental method that generates a pseudo-P curve. This curve shares the same profile as the plating current curve (which can be simulated but not directly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results